Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers,
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology,
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are
Beauty supply retailer Sally Beauty (NYSE:SBH) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $937.9 million.
Beer company Molson Coors (NYSE:TAP) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 2% year on year to $2.74
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.2% year on
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up
Honda's U.S.-listed shares are rising in premarket trading after the Japanese automaker and ailing domestic rival Nissan said they have called off merger
Cloud monitoring software company Datadog (NASDAQ:DDOG) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 25.1% year
S&P Global completed the list of top credit rating agencies to warn that an "unprecedented" U.S. withdrawal from the World Bank and other top
